PIPELINE
Our primary development activities are focused around
oral route.  Our current product portfolio consists of
products in Gastro Intestinal (GI), Cardiovascular (CV),
Anti-viral (HIV), Anti-bacterials and Central Nervous
System (CNS) area.  Primarily, we focus on solid and
liquid dosage forms.  However, our in-house work has
resulted into a notable work in other dosage form.

We have applied for a unique patent to deliver
leukotriene antagonist and similar class of compounds
via Intra-nasal delivery.  We have observed significant
clinical benefits with patients of all ages, genders and
ethnic diversity. We are exploring partnership for this
opportunity.